Long-term PERG monitoring of untreated and treated glaucoma suspects.
Adult
Antihypertensive Agents
/ therapeutic use
Disease Progression
Electroretinography
/ methods
Female
Humans
Male
Middle Aged
Nerve Fibers
/ physiology
Ocular Hypertension
/ diagnosis
Pattern Recognition, Visual
/ physiology
Retinal Ganglion Cells
/ physiology
Retrospective Studies
Visual Field Tests
/ methods
Visual Fields
/ physiology
Glaucoma suspects
Pattern electroretinogram
Retinal ganglion cell function
Retinal nerve fiber layer thickness
Journal
Documenta ophthalmologica. Advances in ophthalmology
ISSN: 1573-2622
Titre abrégé: Doc Ophthalmol
Pays: Netherlands
ID NLM: 0370667
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
06
11
2019
accepted:
02
03
2020
pubmed:
11
3
2020
medline:
10
10
2020
entrez:
11
3
2020
Statut:
ppublish
Résumé
To investigate long-term structural and functional progression of untreated and treated glaucoma suspects (UGS and TGS). Retrospective analysis of serial steady-state pattern electroretinogram (PERG), mean retinal nerve fiber layer thickness (RNFLT), and standard automated perimetry mean deviation (SAP-MD) in UGS (N = 20) and TGS (N = 18). Outcome measures were the rates of change (linear regression slopes) of PERG amplitude, PERG phase, mean RNFLT, and SAP-MD over 9.8 ± 1.3 years (15.6 ± 4.2 visits). The number of patients with significant (P < 0.05) progression slopes for PERG amplitude, PERG phase, RNFLT, and SAP-MD was, respectively, UGS: 5, 0, 4, 2; TGS: 8, 2, 6, 5. In UGS, outcome measures were not correlated with each other. In TGS, both PERG amplitude and RNFLT were significantly (P < 0.05) correlated with SAP-MD (R ≥ 0.58), while PERG amplitude and RNFLT were not correlated with each other (R = 0.43, P = 0.064). The rate of change of SAP-MD was predicted (P < 0.05) by a linear combination of RNFLT slope and PERG amplitude slope. Results substantiate and extend previous results showing that steady-state PERG amplitude progressively decreased over time in a proportion of glaucoma suspects, with relatively steeper slope in TGS compared to UGS. RNFLT progression also had a steeper slope in TGS compared to UGS; however, progressions of PERG amplitude and RNFLT were not significantly correlated. Both PERG progression and RNFLT progression independently contribute to prediction of visual field progression.
Identifiants
pubmed: 32152920
doi: 10.1007/s10633-020-09760-5
pii: 10.1007/s10633-020-09760-5
pmc: PMC7483546
mid: NIHMS1573864
doi:
Substances chimiques
Antihypertensive Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
149-156Subventions
Organisme : NEI NIH HHS
ID : P30 EY014801
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY014957
Pays : United States
Organisme : NEI NIH HHS
ID : RO1 EY014957
Pays : United States
Références
Ophthalmology. 2018 Nov;125(11):1817-1827
pubmed: 30322450
J Glaucoma. 2015 Apr-May;24(4):278-85
pubmed: 24633086
Exp Eye Res. 2018 Apr;169:48-53
pubmed: 29374551
Invest Ophthalmol Vis Sci. 2013 Mar 28;54(3):2346-52
pubmed: 23412088
J Glaucoma. 2013 Mar;22(3):219-25
pubmed: 22071557
Invest Ophthalmol Vis Sci. 2011 Jun 16;52(7):4300-6
pubmed: 21372021
Vision Res. 1992 Jul;32(7):1199-209
pubmed: 1455694
Ophthalmology. 2004 Jan;111(1):161-8
pubmed: 14711729
J Glaucoma. 2011 Mar;20(3):133-8
pubmed: 20577113
Curr Opin Ophthalmol. 2006 Apr;17(2):196-202
pubmed: 16552256
Arch Ophthalmol. 1999 May;117(5):573-83
pubmed: 10326953
Doc Ophthalmol. 2013 Dec;127(3):227-38
pubmed: 24126828
J Glaucoma. 2018 Feb;27(2):121-132
pubmed: 29329137
Doc Ophthalmol. 2013 Feb;126(1):1-7
pubmed: 23073702
Transl Vis Sci Technol. 2018 Sep 13;7(5):6
pubmed: 30221072
Cell Tissue Res. 2013 Aug;353(2):287-96
pubmed: 23525754
Optom Vis Sci. 2008 Jun;85(6):386-95
pubmed: 18521020
Curr Opin Ophthalmol. 2016 Mar;27(2):118-24
pubmed: 26720775
Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):659-63
pubmed: 22247462
Ophthalmology. 2009 Jul;116(7):1271-7
pubmed: 19395086
Ophthalmology. 2005 Jan;112(1):10-9
pubmed: 15629814